COPD Trials in Birmingham, United States
Conditions / COPD / Birmingham, United States
COPD has been the subject of sustained clinical investigation across multiple research sites.
27 total trials for this combination
Showing top 10 of 27 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01969344 | Study of COPD Subgroups and Biomarkers | ACTIVE_NOT_RECRUITING | — |
| NCT04320342 | A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD | COMPLETED | PHASE3 |
| NCT00667797 | Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Subjects | COMPLETED | PHASE4 |
| NCT00475007 | Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema | COMPLETED | NA |
| NCT01966107 | Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients. | COMPLETED | PHASE4 |
| NCT03256773 | High Resolution Micro OCT Imaging | ACTIVE_NOT_RECRUITING | — |
| NCT03084796 | A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE2 |
| NCT00463567 | 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2/PHASE3 |
| NCT00685841 | A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 |
| NCT02465567 | Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 in Subjects With Moderate to Very Severe COPD (Ethos) | COMPLETED | PHASE3 |